Detalhe da pesquisa
1.
Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone.
Bioorg Chem
; 128: 105905, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710525
2.
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design.
Eur J Med Chem
; 229: 114043, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929581
3.
The in vivo antinociceptive and µ-opioid receptor activating effects of the combination of N-phenyl-2',4'-dimethyl-4,5'-bi-1,3-thiazol-2-amines and naloxone.
Eur J Med Chem
; 167: 312-323, 2019 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30776693